Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
Does Johnson & Johnson's Split Make Sense?
Motley Fool
Wed, 01/12/22 - 11:15 pm
Tags:
JNJ
JPM 2022: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B+
Fierce Pharma
Mon, 01/10/22 - 11:33 pm
Tags:
JPMHC 2022
,
JNJ
,
Pharma CEOs
,
consumer health
,
Joaquin Duato
#JPM22, Day 1: Bristol Myers Squibb's blockbuster losses of exclusivity, Novartis' spending plans and more
Fierce Pharma
Mon, 01/10/22 - 11:38 am
Tags:
JPMHC 2022
,
Bristol Myers Squibb
,
Revlimid
,
Novartis
,
Moderna Therapeutics
,
JNJ
,
Trikafta
J&J’s booster shot provides strong protection against severe disease from Omicron, a study says.
NY Times, NY
Mon, 01/3/22 - 10:53 pm
Tags:
JNJ
,
vaccines
,
COVID-19
,
boosters
,
Omicron COVID-19 variant
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Tags:
Alnylam Pharmaceuticals
,
Bio-Thera Solutions
,
BioArctic
,
Biogen
,
BridgeBio Pharma
,
Daiichi Sankyo
,
Eisai
,
JNJ
,
Madrigal Pharmaceuticals
,
Merck
,
Sutro BioPharma
,
Tasly Pharmaceutical Group
Teva suffers trial loss in New York's landmark opioid case
Fierce Pharma
Thu, 12/30/21 - 08:03 pm
Tags:
Teva Pharmaceutical
,
AbbVie
,
JNJ
,
New York
,
legal
,
opioids
,
opioid crisis
J&J goes after another FDA approval for a cancer bispecific
Pharmaforum
Thu, 12/30/21 - 10:53 am
Tags:
JNJ
,
bispecific antibodies
,
cancer
,
FDA
,
Janssen
,
teclistamab
,
Multiple Myeloma
Robotic Surgery: Who Will Be the Next Top Dog?
Medical Devices and Diagnostics Industry
Sat, 12/18/21 - 10:49 pm
Tags:
robotic surgery
,
devices
,
Medtech
,
Intuitive Surgical
,
JNJ
,
Medtronic
Citing blood clot risks, CDC advisers recommend mRNA pandemic vaccines over J&J shot
Fierce Pharma
Fri, 12/17/21 - 12:02 am
Tags:
JNJ
,
vaccines
,
COVID-19
,
blood clots
,
FDA
,
MRNA
CDC eyes safety of J&J COVID jab as EU backs booster
Pharmaforum
Thu, 12/16/21 - 11:07 am
Tags:
JNJ
,
vaccines
,
COVID-19
,
Europe
,
boosters
Humana, Centene sue drugmakers, alleging anticompetitive practices on HIV drugs
BioPharma Dive
Thu, 12/16/21 - 10:45 am
Tags:
Humana
,
Centene
,
generics
,
anticompetitive practices
,
Gilead Sciences
,
Bristol Myers Squibb
,
JNJ
,
Teva Pharmaceuticals
ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, Darzalex 4-drug regimens in myeloma
Fierce Pharma
Sun, 12/12/21 - 11:33 pm
Tags:
ASH2021
,
Sanofi
,
JNJ
,
Sarclisa
,
Darzalex
,
Multiple Myeloma
J&J squares up to Big Pharma rivals with extra RSV vaccine data
Fierce Biotech
Tue, 12/7/21 - 10:56 am
Tags:
JNJ
,
vaccines
,
RSV
,
Pfizer
,
GSK
J&J booster effective for Pfizer vaccine recipients, study shows
Beckers Hospital Review
Mon, 12/6/21 - 11:49 pm
Tags:
JNJ
,
Pfizer
,
COVID-19
,
vaccines
,
boosters
New CEOs Set to Lead Top Medtech Companies in 2022
Medical Devices and Diagnostics Industry
Mon, 12/6/21 - 11:33 pm
Tags:
devices
,
Medtech
,
medtech CEOs
,
iCAD
,
JNJ
,
Integra LifeSciences
Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?
Motley Fool
Sun, 12/5/21 - 10:49 pm
Tags:
Bristol Myers Squibb
,
JNJ
,
clinical trials
,
bloodthinners
,
milvexian
Researchers move closer to deciphering blood clots from AstraZeneca, J&J's Covid-19 vaccines
Endpoints
Fri, 12/3/21 - 10:57 am
Tags:
JNJ
,
AstraZeneca
,
blood clots
,
vaccines
,
COVID-19
Aspen Pharmacare, pursuing J&J vaccine license, aims to shore up local capacity and quash shot inequality in Africa
Fierce Pharma
Thu, 12/2/21 - 10:59 am
Tags:
Aspen Pharmacare
,
JNJ
,
COVID-19
,
vaccines
,
Africa
J&J and Sanofi's multiple myeloma tit-for-tat continues, as subcutaneous Darzalex wins combo approval
Endpoints
Thu, 12/2/21 - 10:57 am
Tags:
JNJ
,
Sanofi
,
Multiple Myeloma
,
Sarclisa
,
Kyprolis
,
Darzalex
Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says
Fierce Pharma
Wed, 12/1/21 - 11:28 am
Tags:
M&A
,
pharma industry
,
Big Pharma
,
JNJ
,
Pfizer
,
Moderna Therapeutics
,
Novartis
,
BioNTech
,
GSK
Pages
« first
‹ previous
…
23
24
25
26
27
28
29
30
31
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.